[1]
A. MA, “DISCOVERY OF POTENTIAL GSK-3β INHIBITORS AGAINST ALZHEIMER’S DISEASE: IN SILICO DESIGN AND PHARMACOKINETIC EVALUATION OF N-(ANTHRACENE-1-YL)-2-PHENOXYACETAMIDE ANALOGS”, Int J App Pharm, vol. 18, no. 4, Apr. 2026.